SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950123-17-011384
Filing Date
2017-12-15
Accepted
2017-12-15 16:06:49
Documents
101
Period of Report
2017-12-15
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 FORM 8-K mack-8k_142.htm 8-K 40376
2 EX-23.1 mack-ex231_186.htm EX-23 2407
3 EX-99.1 mack-ex991_20161231.htm EX-99 2901914
  Complete submission text file 0000950123-17-011384.txt   12030995

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT mack-20161231.xml EX-101.INS 2542137
5 XBRL TAXONOMY EXTENSION SCHEMA mack-20161231.xsd EX-101.SCH 101515
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mack-20161231_cal.xml EX-101.CAL 92653
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mack-20161231_def.xml EX-101.DEF 419457
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE mack-20161231_lab.xml EX-101.LAB 712648
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mack-20161231_pre.xml EX-101.PRE 617140
Mailing Address ONE KENDALL SQUARE SUITE B7201 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE SUITE B7201 CAMBRIDGE MA 02139 617-441-1000
MERRIMACK PHARMACEUTICALS INC (Filer) CIK: 0001274792 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35409 | Film No.: 171259050
SIC: 2834 Pharmaceutical Preparations